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Abstract 
Here we describe new fluorescent probes based on fluorescein and rhodamine that 
provide reversible, real-time insight into cellular redox status. The new probes 
incorporate bio-imaging relevant fluorophores derived from fluorescein and 
rhodamine linked with stable nitroxide radicals such that they cannot be cleaved, 
either spontaneously or enzymatically by cellular processes. Overall fluorescence 
emission is determined by reversible reduction and oxidation, hence the steady state 
emission intensity reflects the balance between redox potentials of critical redox 
couples within the cell. The permanent positive charge on the rhodamine-based 
probes leads to their rapid localisation within mitochondria in cells. Reduction and 
oxidation also leads to marked changes in the fluorophore lifetime, enabling 
monitoring by fluorescence lifetime imaging microscopy. Finally, we demonstrate 
that administration of a methyl ester version of the rhodamine-based probe can be 
used at concentrations as low as 5 nM to generate a readily detected response to redox 
stress within cells as analysed by flow cytometry.  
 
 
Key Words 
Nitroxide 
Fluorescent probe 
Mitochondria 
Redox Status 
Oxidative Stress 
 
 
  
 3 
 
Introduction 
Nitroxide free radicals, or more correctly aminoxyls, have been known for more than 
170 years and can act as antioxidants, either directly or after conversion to a 
hydroxylamine. The first reported example of a nitroxide free radical was that of 
Frémy’s salt, which was synthesised in 1845 [1]. Although it is likely that there were 
nitroxides generated in Piloty’s reactions of potassium cyanide with isobutyramidine 
in the early 1900s [2], it would take a further 50 years and the development of 
magnetic resonance spectroscopy before the work of Lebedev [3] and later Henderson 
[4] sparked a remarkable period where nitroxides, spin labels and spin trapping 
generated insight into materials science, structural biology and the understanding of 
reactive intermediates. As nitroxides are stable towards many solvents and reagents as 
well as the atmosphere, while possessing an unpaired spin that rapidly scavenges 
reactive free radicals, they were quickly exploited as potent antioxidants. Even today, 
modern “plastics” contain significant levels of hindered amine stabilisers that are 
precursors to nitroxides [5], thereby retarding oxidation and extending application 
lifetimes. In free radical biology it was rapidly determined that nitroxides interact 
with superoxide in vitro [6] acting as superoxide dismutase mimetics [7], as they 
reproduce some of the impact of those enzymes that degrade superoxide. However, 
for kinetic reasons, the antioxidant effects reported for nitroxides in vivo most likely 
follow their rapid metabolic conversion to hydroxylamines [8]. The remarkable 
chemistry of nitroxides arises from them being persistent entities existing in between 
less stable one-electron reduction and one-electron oxidation products, each of which 
can be accessed at biologically relevant redox potentials (Figure 1A.).  
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A. 
 
B. 
 
C. 
 
Figure 1. A. Nitroxides exist at an oxidation state between more oxidised (oxoammoninium ions) and 
more reduced (hydroxylamine) forms. B. When exposed to living systems nitroxides are reduced to 
non-radical hydroxylamines. This transformation is reversed in the presence of oxygen and other 
oxidising species including many reactive oxygen species (ROS). The steady state level of nitroxides 
can be monitored by EPR, or by fluorescence when fluorophores are incorporated within the structure. 
C. Carboxyisoindoline nitroxides (1) serve as precursors for fluorescein-based pro-fluorescent 
nitroxides (2) and rhodamine-based nitroxides (5 and 8) 
 
Subtleties in the chemical structure, including the ring size, type and 
substitution influence these redox potentials [9]. However, it is important to note that, 
despite being known as antioxidants, most nitroxides exposed to living systems, are 
reduced to the non-radical hydroxylamine [10]. This demonstrates that, within a 
living system, nitroxides are treated as oxidants, requiring cells to use some of their 
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reductive capacity to reduce the nitroxide to the non-radical species. Whilst this rapid 
reduction leads to signal loss and limits electron paramagnetic resonance (EPR) 
imaging, it also presents a unique means to assess the redox state of redox couples 
within living systems that interact with nitroxides and their reduced and/or oxidised 
products. More rapid reduction of the nitroxide represents functional reducing 
capacity, whereas slower reduction reflects compromised reducing capacity, which 
may indicate disease and consequent cellular dysfunction. Complicating the situation 
is oxygen, which can re-oxidise the hydroxylamine back to the nitroxide. Thus, the 
steady-state amount of nitroxide present in a living system depends on a range of 
factors including: the ease of oxidation of the hydroxylamine; the concentration and 
nature of oxidising species; the speed of the reduction of the nitroxide; the localisation 
of the nitroxide within the cell; the polarity/lipophilicity and charge of the molecule; 
and also the ease with which nitroxides can interact with reductive enzymes and other 
biologically relevant reducing agents such as ascorbate, ubiquinol and, indirectly, 
glutathione. Importantly this reversibility of nitroxide oxidation and reduction imparts 
an advantage to the use of nitroxides as biological probes. A probe that establishes a 
paramagnetic/diamagnetic equilibrium in response to local conditions within a 
biological system will respond to, in real-time and reversibly, the overall redox status 
of cognate redox couples within the cellular system being investigated and will 
respond in real time to any changes to these couples, such as those in response to 
pathology, drugs and environmental stresses (Figure 1B.). However it is important to 
note that these responses will be dominated by the entirety of the biological milieu 
and that there is not one “redox couple” or “redox state” reported on by these probes. 
In an earlier attempt to exploit these properties we designed [11] a structurally 
efficient fluorescein-based, dual mode fluorescent probe (Figure 1C.: 2a. R2 = –CH3) 
designed to respond to aspects of the redox status of the cell. The combination of a 
fluorophore in close proximity to the spin of a nitroxide leads to substantial quenching 
of emission of the fluorophore. We coined the term “pro-fluorescence” [12,13] to 
describe this effect, by analogy with the “pro-drug” terminology widely used in 
medicinal chemistry and which reflects how metabolism and chemical conversion 
reveals the active fluorophore. The probe 2a contained a widely exploited fluorophore 
(fluorescein) suitable for the lasers used in confocal microscopy and flow cytometry. 
It also had a built-in nitroxide that put the spin in close proximity to the fluorophore 
for maximum quenching [14] and, most importantly, did not allow enzymatic or 
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spontaneous fluorophore-nitroxide cleavage. However, biological systems, even those 
compromised by disease, still maintain some degree of redox homeostasis and thus 
should still able to rapidly reduce the nitroxide moiety present in 2a and switch on 
fluorescence. To achieve significant differentiation between normal and stressed cells, 
it was necessary to interfere with redox homeostasis by adding 2-deoxyglucose to 
block glycolysis and thus shift the cells to more oxidising conditions. We then added 
rotenone to block mitochondrial complex I and generate reactive oxygen species 
(ROS). The subsequent changes in cellular redox balance could be followed by flow 
cytometry using our pro-fluorescent nitroxide (PFN) probe and allowed us to 
demonstrate changes in probes status reflecting redox couple changes within the cell.  
Recently we [15] and others [16] have introduced further structural changes to 
antioxidant nitroxides that have been used to intervene in enzyme and neutrophil 
dysfunction. These changes decrease the rate of reduction and prolong nitroxide 
lifetime. Specifically, replacement of the four methyl groups that cradle the nitroxide 
spin with larger, more electron-rich ethyl groups, extends the nitroxide lifetime both 
in vitro [15] and in vivo [16]. Building on these ideas, we subsequently developed 
tetraethylisoindoline nitroxides substituted with carboxy groups [17] and used these to 
make a fluorescein-based PFN (2b, R2 = –CH2CH3). While the four ethyl groups in 
the PFN 2b convey some advantages over first generation PFN probes, fluoresceins 
have poor emissivity at low pH and are susceptible to photobleaching. Consequently, 
an extension to this approach generated a rhodamine analogue (5), which could be 
synthesised from 2b. Rhodamines are less pH sensitive and less prone to 
photobleaching. Most importantly, the positive charge on rhodamines leads to their 
accumulation in mitochondria and this characteristic was further enhanced through 
the esterification of 5 to give 8.  
The mitochondrion is an important organelle, with a critical influence over the 
redox status of the cell. Mitochondria are a major focus for drug development, 
reflecting their key role in a range of pathologies [18-22], as well as being a major site 
of cellular radical production. A number of nitroxides [23-26] have been described 
that are targeted to mitochondria. These have mostly involved triphenylphosphonium 
ions following the early work by Murphy and co-workers [27] suggesting the use of 
charged lipophilic catiion side-chains to induce enhanced delivery of antioxidants into 
mitochondria. A notable alternative to this approach has been the elegant 
methodology of Kagan and Wipf et al. [28, 29], who used peptides based on the 
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natural product hemigramicidin to induce mitochondrial uptake. To our knowledge, 
all of the mitochondria-targetted compounds described involve rapidly reduced 
tetramethyl nitroxides and/or cleavable linkers between the nitroxide and the side-
chain.  
Accumulation in response to the mitochondrial and plasma membrane 
potential can lead to the many hundred-fold enhanced concentrations of nitroxides in 
the mitochondrial matrix [30]. However it is important to note that, no matter the 
equilibrium position, these probes rapidly shuttle in and out of the mitochondria, with 
these organelles representing only a proportion of a cell’s total volume. Consequently, 
even mitochondrially-targeted nitroxides are also present in the rest of the cell, where 
they are subject to differing biochemical processes. One of the challenges for all 
mitochondrial probes therefore, is managing the response arising from non-
mitochondrially localized probes exposed to significantly different chemical 
environments from those of the mitochondria. To address this, an ideal mitochondria-
targeted PFN probe should be less responsive in the cytosol and extra-cellular 
environment, predominantly switching on inside the mitochondria. The slower 
reduction of the tetra-ethyl, rhodamine-based nitroxide 5 represents one means to 
achieve this goal.  
Herein we extend our earlier work and report the synthesis and properties of 
carboxyisoindoline nitroxides and their conversion into redox-responsive fluorescein 
and rhodamine pro-fluorescent probes that respond in real-time and reversibly to 
changes in the redox status of certain redox couples in living systems. The presence of 
bulky ethyl groups limits fluorescence switch-on to highly reducing environments and, 
in combination with the positively charged rhodamine structure, effectively confines 
the fluorescence response to within mitochondria. This makes the probes suitable for 
imaging redox changes within cells for extended periods of time and has implications 
for developing our understanding of mitochondrial metabolism and pathology.  
 
Materials and Methods 
General methods 
 
Reagents and probes 
MitoTracker Green, LysoTracker Blue, MitoSox and Hoechst 33258 were supplied by 
Molecular Probes. All solvents used were Analytical Reagent (AR) grade and all 
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other chemical reagents were of Laboratory Reagent (LR) quality or better and were 
used as supplied by the manufacturer.  
 
Preparation of compounds 
Analytical thin-layer chromatography (TLC) was performed using Merck Silica Gel 
60 F254 TLC plates. Preparative column chromatography was performed using Merck 
Silica Gel 60 (mesh 230-400). Mass spectra were recorded using a Bruker Apex 3 
Fourier transform ion cyclotron resonance mass spectrometer with a 4.7 T magnet. 
Analytical HPLC was performed on a Hewlett Packard 1100 series HPLC, using an 
Agilent prep-C18 scalar column (10 μm, 4.6 × 150 mm) at a flow rate of 1 mL/min. 
Fluorescence spectra were obtained using either a Varian Cary Eclipse fluorescence 
spectrophotometer (Agilent Technologies, USA) equipped with a standard multi-cell 
Peltier thermostatted sample holder, or a Shimadzu RF-5301PC fluorescence 
spectrophotometer (Shimadzu Scientific Instruments Inc., Japan) equipped with a 
magnetic stirrer.  
 
 
Scheme 1. Carboxyisoindoline nitroxides (1) are converted to fluorescein-based pro-fluorescent 
nitroxides (2) and rhodamine-based nitroxides (5). Nitroxides such as 2 and 5 may be permanently 
converted to the close structural, but non-radical, methoxyamine analogues (7b) by treatment with iron 
and hydrogen peroxide in dimethylsulfoxide. 
 
Synthesis of tetramethyl and tetraethyl nitroxides (1a-d)  
These nitroxides were synthesised following procedures described by Fairfull-Smith 
et al. [17] and references therein. 
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Synthesis of tetramethylfluorescein nitroxide (2a).  
This probe was synthesised following the method described by Morrow et al. [11] 
 
Synthesis of tetraethylfluorescein nitroxide (2b).  
5,6-Dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (1b) (150 mg, 0.45 mmol) was 
dissolved in acetic anhydride (Ac2O, 3 mL) and heated for 1 hr at 95C. The solution 
was returned to room temperature and the acetic anhydride was removed by 
distillation under reduced pressure to give an orange solid. This solid was taken up in 
methane sulfonic acid (MeSO3H, 1.5 mL) and resorcinol (99 mg, 0.90 mmol, 2 equiv) 
was added. The mixture was heated at 85C for 16 hr before being poured onto ice. 
NaOH (5 M) was carefully added to dissolve the precipitate and the solution was 
stirred for 15 min. The solution was cooled to 0C and acidified with HCl (conc.). 
The resultant brown precipitate was filtered and thoroughly washed with cold H2O 
and dried under high vacuum. Purification of the crude product by flash column 
chromatography (5 % MeOH / 95 % CHCl3) gave an orange powder (193 mg, 86 %); 
+EI MS found 500.2082 (1.8 ppm from calc. mass of C30H30NO6

); m/z 500 (M
+
, 
100 %), 472 (35), 446 (15), 427 (25), 411 (32); found: C, 71.82; H, 6.11; N, 2.89. 
C30H30NO6
 
requires C, 71.98; H, 6.04; N, 2.80. 
 
Synthesis of tetramethylfluorescein triflate nitroxide (4a).  
To a solution of the fluorescein nitroxide (2a, 50 mg, 0.112 mmole) in DCM (0.15 
mL), triethylamine (Et3N, 34 L, 2.44 mmole, 2.2 equiv.) was added and stirred at 
0°C for 5 min whereupon trifluoromethanesulfonyl chloride was added (42 mg, 26 L, 
0.772 mmol, 2 equiv.) The mixture was allowed to return to room temperature and 
stirred over a period of 6 hr. A volume of DCM (~20 mL) was added to the reaction 
mixture, and the organic phase was washed with 2 M HCl (2 × 40 mL) and brine (20 
mL). The DCM extract was dried over Na2SO4 and the solvent was evaporated under 
reduced pressure. The crude material was purified by flash chromatography (SiO2, 
98% DCM/2% acetone) to give the triflate derivative as a white solid (67.4 mg, 85 %). 
+ESI HRMS found (M+H)
+
 709.05055 (0.8 ppm from calc. mass of C28H21NO10F6S2. 
 
Synthesis of tetraethylfluorescein triflate nitroxide (4b).  
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Trifluoromethanesulfonyl chloride (152 mg, 96 μL, 0.90 mmol, 4 equiv) was added 
dropwise to a solution of tetraethyl fluorescein nitroxide 2b (113 mg, 0.23 mmol) and 
Et3N (138 μL, 0.99 mmol, 4.4 equiv) in 2 mL of dichloromethane (DCM) at 0°C. 
The mixture was allowed to return to room temperature over a period of 1 hr. A 
volume of DCM (~40 mL) was added to the reaction mixture, and the organic phase 
was washed with 2 M HCl (2 × 40 mL) and brine (40 mL). The DCM extract was 
dried over Na2SO4 and the solvent was evaporated under reduced pressure. The crude 
material was purified by flash chromatography (SiO2, DCM) to give the triflate 
derivative as a pale yellow solid (147 mg, 85 %). Crystals suitable for elemental 
analysis could be obtained by recrystallisation from hexane (76 mg, 52 % recovery). 
+ESI HRMS found (M+H)
+
 765.1135 (0.3 ppm from calc. mass of C32H29NO10F6S2) 
and (M+Na)
+
 787.0973 (2.0 ppm from calc. mass of C32H28NO10F6S2Na); found: C, 
50.27; H, 3.76; N, 1.88; S, 8.43. C32H28NO10F6S2
 
requires C, 50.26; H, 3.69; N, 1.83; 
S, 8.39. 
 
Synthesis of tetraethylrhodamine nitroxide (5b).  
A Schlenk tube was flame dried under high vacuum and returned to room temperature 
under a flow of argon. The reaction vessel was charged with Pd(OAc)2 (1.8 mg, 0.008 
mmol, 10 mol% Pd), ()-BINAP (7.3 mg, 0.012 mmol, 15 mol%) and toluene (2 mL). 
This mixture was stirred for 10 min until a peach-colored suspension had formed. 
Tetraethylfluorescein triflate nitroxide (4b) (60 mg, 0.08 mmol), pyrrolidine (16 L, 
0.18 mmol, 2.4 equiv) and Cs2CO3 (72 mg, 0.22 mmol, 2.8 equiv) were then added to 
the mixture and the vessel was flushed with argon for 10 min. The temperature was 
raised to 85C, the vessel was sealed and the reaction mixture was stirred at this 
temperature for 24 h. A volume of Et2O (~40 mL) was added to the reaction mixture 
and the organic phase was washed the HCl (2 M, 3  40 mL). The acidic aqueous 
phase was cooled to 0C and made basic by the dropwise addition of NaOH (10 M). 
The product was extracted into Et2O (3  40 mL), the organic phases were combined 
and subsequently washed with brine and dried over Na2SO4. The solvent was 
removed under reduced pressure and the crude solid was purified by flash column 
chromatography (solvent gradient from CHCl3 + 0.5 % v/v Et3N to 90 % CHCl3/10 % 
MeOH + 0.5 % v/v Et3N). The purified fraction was isolated as a purple solid (20.1 
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mg, 42 %). +ESI HRMS found (M+H)
+
 607.3413 (0.5 ppm from calc. mass of 
C38H45N3O4). 
 
Synthesis of methyl adduct of tetraethylrhodamine nitroxide (7b).  
Hydrogen peroxide solution (30%, 3.74 uL, 3.30 × 10
-5
 mol) was added dropwise to a 
solution of tetraethylrhodamine nitroxide 5b (10 mg, 1.65 × 10
-5
 mol) and iron (II) 
sulphate heptahydrate (9.2 mg, 3.30 × 10
-5
 mol) in DMSO (1 mL). The resulting 
solution was stirred at room temperature for 40 min and then diluted with aqueous 
sodium hydroxide (2.5 M, 10 mL). The mixture was extracted with diethyl ether (3 × 
30 mL) and the combined organic layers dried (anhydrous Na2SO4) and concentrated 
in vacuo. Purification by silica column chromatography (eluent 0.5% Et3N/CHCl3 → 
0.5% Et3N/5% MeOH/CHCl3) gave 7b as a pale pink oil (5 mg, 49%). 
 
Synthesis of tetraethylrhodamine nitroxide methyl ester (8b).  
Acetyl chloride (200 µL, 2.8 mmol) was added dropwise to a suspension of 
tetraethylrhodamine nitroxide 5b (11.2 mg, 1.85 mmol) in anhydrous methanol (1.5 
mL). The resulting solution was heated at 50
o
C for 2 days. The reaction mixture was 
diluted with water and extracted with EtOAc and CHCl3. The combined organic 
layers were dried (anhydrous MgSO4) and concentrated in vacuo to give 8b as a 
sticky pink solid (0.063 g, 55%). 
 
Synthesis of methyl adduct of tetraethylrhodamine nitroxide (10b).  
Hydrogen peroxide solution (30%, 3.74 uL, 3.30 × 10
-5
 mol) was added dropwise to a 
solution of tetraethylrhodamine nitroxide methyl ester 8b (10 mg, 1.65 × 10
-5
 mol) 
and iron (II) sulphate heptahydrate (10 mg, 3.2 × 10
-5
 mol) in DMSO (1.5 mL). The 
resulting solution was stirred at room temperature for 40 min and then diluted with 
brine. The mixture was extracted with CHCl3 (3 × 30 mL) and the combined organic 
layers dried (anhydrous Na2SO4), concentrated in vacuo and dried under high vacuum 
at 35
o
C to remove all traces of DMSO. The resulting solid was dissolved in water and 
extracted into DCM. The combined DCM layers were dried (anhydrous Na2SO4) and 
concentrated in vacuo to give 10b as a purple solid (10 mg, 50%). 
 
Attempted synthesis of tetramethylrhodamine nitroxide (5a).  
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Tetramethylfluorescein triflate nitroxide (4a) (35 mg, 0.049 mmol), Pd(OAc)2 (1.2 
mg, 0.005 mmol, 10 mol% Pd), ()-BINAP (4.8 mg, 0.008 mmol, 15 mol%), Cs2CO3 
(45 mg, 0.138 mmol, 2.8 equiv and pyrrolidine (12.5 L, 0.15 mmol, 3 equiv) were 
dissolved in anhydrous dioxane (0.1 mL) and heated under argon at 100 °C for 16 h. 
The reaction was cooled HCl (2 M, 15 mL) was added and the acidic phase was 
washed with Et2O (2 x 20 mL). The aqueous phase was removed under reduced 
pressure and the residue taken up in EtOH (~10 mL). Et2O was added to help 
precipitate inorganic salts and the solution filtered and then evaporated to dryness 
under vacuum. The crude product was partially purified by flash column 
chromatography (80% EtOAc / 20% EtOH with ~1% Et3N added to limit streaking) 
to give purple solid (7 mg, < 25%) which melted with decompositon >300 °C. +ESI 
HRMS gave a peak (M)
+
 551.27916 (1.4 ppm from calc. mass of C34H37N3O4). 
However there were other peaks present and HPLC gave a broadened peak reflecting 
limited purity. 
 
Cell culture methods 
Cell lines were maintained in exponential growth as monolayers in Dulbecco’s 
modified Eagle’s medium (DMEM) or Advanced DMEM. For neonatal foreskin 
fibroblasts immortalised with human telomerase reverse transcriptase (NFF hTERT), 
DMEM was supplemented with 12% foetal calf serum (FCS), and 1% penicillin-
streptomycin antibiotics; for DLD-1 colorectal adenocarcinoma cells, 4% FCS, 1% 
glutamine and 1% antibiotic-antimycotic were used. The cells were incubated under 
standard culturing conditions at 37°C, with 5% (v/v) CO2 under humidified conditions. 
For imaging experiments, phenol red containing DMEM was exchanged for phenol-
red free DMEM. NFF hTERT were also regularly tested for mycoplasma 
contamination using MycoAlert (Lonza) and Hoechst 33258 staining.  
 
Flow cytometry 
NFF hTERT were cultured as detailed above to sub-confluent (approximately 2 × 10
5
 
cells per mL) and confluent (approximately 6 × 10
5
 cells per mL) levels over a period 
of 48 h in 6-well plates. Cells were treated with nitroxide probe (5b, 6b: 1 μM. 8b, 
9b: 5 nM) or MitoSOX
TM
 in complete media at 37°C, 5% CO2 for 45 min, after which 
they were washed with PBS and then incubated with various concentrations of 
rotenone or antimycin for 15 min (Fs). All control wells (Fc) were treated with media 
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containing vehicle (DMSO). Cells were then detached using trypsin/versene and 
pelleted via centrifugation at 1200 rpm for 4 min. The supernatant was removed and 
the cells were resuspended in 1 mL PBS in preparation for flow cytometry using a 
Becton–Dickinson LSRFortessa Flow Cytometer. All samples were kept in the dark 
to avoid photobleaching prior to measurement. Between each run, the system was 
rinsed and cleaned with bleach (70% v/v) to avoid cross-contamination. Probes 5b, 6b, 
8b and 9b were excited with a 561 nm laser and emission was detected using a 582/15 
nm filter set. MitoSox
TM
 was excited with a 488 nm laser and emission was detected 
using a 582/15 nm filter set. Data were collected from a total of 10000 cells per 
sample. Sample data were gated on acquisition to exclude oversized/doublets and 
necrotic material. Mean fluorescence intensity values from control (Fc) and treated 
(Fs) samples were used to calculate the percentage change in fluorescence intensity 
(% Δ F) after treatment using the following equation: 
  
      
       
   
     
 
Fluorescence microscopy 
Fluorescence imaging studies to determine subcellular localisation of nitroxide probes 
were performed using a Deltavision wide-field microscope (Applied Precision) with 
an enclosed environmental chamber (37°C, 5% CO2). Cells were plated into 8-well 
chamber slides (Ibidi) at a density of 1.5 ×10
4
 cells per well (200 μL). The following 
day, cells were incubated with combinations of nitroxide (5b, 6b: 1 μM or 5 nM. 8b, 
9b: 5 nM) and various fluorescent probes which target subcellular organelles (1.6 µM 
Hoechst 33258 (nucleus), 100 nM MitoTracker
TM
 Green (mitochondria) or 50 nM 
LysoTracker
®
 Blue (lysosomes)). Briefly, incubating medium was replaced with 200 
μL of phenol red free complete media containing the dye combinations. Typically, 
cells were incubated for 45 min at 37°C, 5% CO2, whereupon they were washed (1×) 
with 200 μL of phenol red free complete media. Phenol red free complete media was 
replaced and cells imaged. Hoechst 33258 and LysoTracker
®
 Blue were imaged using 
a DAPI filter set (Ex: 390/18 nm, Em: 435/48 nm), whilst nitroxides and 
MitoTracker
TM
 were visualised with Cy3 (Ex: 541/27 nm, Em: 593/45 nm) and FITC 
filter sets (Ex: 475/28 nm, Em: 523/36 nm), respectively.  
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Fluorescence spectroscopy 
Fluorescence measurements were conducted on a Varian Cary Eclipse fluorescence 
spectrophotometer fitted with a microplate reader accessory or a Shimadzu RF-
5301PC spectrofluorophotometer (Shimadzu Scientific Instruments Inc., Japan) 
equipped with a magnetic stirrer. Fluorescein nitroxide 2 was excited at 490 nm, and 
the emission was detected at the peak around 525 nm or over the range 495–600 nm. 
Reduction reactions with ascorbate and hydrazine were conducted in 0.01 M 
phosphate-buffered saline, pH 7.4 (PBS). Nitroxide probes 2, 5 or 8b, or the 
methoxyamine derivatives, were added to samples at a final concentration of 1 μM, 
or less, from a 10 mM stock solution prepared in DMSO or EtOH/PBS. Stock 
solutions of the probes were stored in a −23 °C freezer until use. As ascorbate in 
solution can be unstable, reduction experiments were performed using a fresh 0.5 M 
stock solution of ascorbate prepared for each experiment with appropriate dilutions 
made to achieve a final ascorbate concentration of 100 μM. 
 
Fluorescence lifetime imaging microscopy (FLIM) 
Fluorescence lifetime images were collected on a Leica TCS SP5 MP FLIM system 
containing a tunable Mai Tai Deep See multi-photon laser with a repetition rate of 80 
MHz (Spectra-Physics) connected to a Leica DMI6000B-CS inverted microscope. 
Samples were illuminated with 820 nm laser and emitted light was collected in the de-
scanned internal FLIM detectors over the 550 – 650 nm using a HCPLAPO 63X 
water-immersion (NA = 1.20) objective lens. The data was collected with the aid of 
the B&H SPCM software and the fluorescence lifetimes were determined using time 
correlated single photon counting (TCSPC) and analysed with SPC Image software 
(version 3.1.0.0). The instrument response function was derived from the decay curve 
of urea. 512 × 512 pixel images were collected and 3X binning applied for analysis to 
ensure that at least 1 × 10
4
 photons per pixel were analysed. Each sample was scanned 
for 120 s. Analysis of fluorescence lifetimes in cells required individually fitted mono 
or bi-exponential curves to obtain average 2 values closest to 1.  
 
Mitochondrial preparations and incubations 
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Bovine heart mitochondrial membranes were prepared as described [31] and stored at 
-80°C and incubated at 0.2 mg protein/mL in KCl buffer. Mitochondria were prepared 
from the hearts of female Wistar rats of 10 to 12 weeks of age (Charles River, UK). 
Animals were killed by stunning followed by cervical dislocation, and the liver and 
heart were removed to ice-cold buffer. Rat heart mitochondria were isolated by 
homogenisation and differential centrifugation at 4C in buffer containing 250 mM 
sucrose, 5 mM Tris-Cl, and 1 mM EGTA (pH 7.4) supplemented with 0.1% (w/v) 
fatty acid-free bovine serum albumin. Protein content of the mitochondrial 
preparations was determined using the biuret assay with bovine serum albumin as a 
standard. Mitochondrial incubations were performed in KCl buffer [120 mM KCl, 10 
mM HEPES, 1 mM EGTA (pH 7.2)], unless stated otherwise. PFN probes 2b and 8b 
were dissolved in EtOH (1 mg/mL) and diluted in PBS to give final concentrations of 
0.2-2.0 M in a total volume of 3 mL of PBS in a 1 × 1 cm2 quartz fluorimeter cell 
loosely capped with a Teflon lid and stirred with a Teflon coated micro stirrer bar at 
400 rpm to keep the membranes or mitochondria in suspension. 
 
Results  
Antioxidant action and bio-availability of tetra-methyl vs tetra-ethyl carboxy 
isoindoline nitroxides 
The original pro-fluorescent fluorescein nitroxide (2a) was derived [11] from 
the dicarboxytetramethylisoindoline nitroxide 1d. The carboxy nitroxide CTMIO (1a) 
is a tetra-methyl nitroxide and such species, along with related antioxidants, have 
efficacy in cells and in vivo [32-39]. Recent attention has focused on more structurally 
hindered tetra-ethyl analogues [16], with the hope of enhancing activity by limiting 
bio-reduction [8]. However, the replacement of the methyl groups in CTMIO (1a) 
with ethyl groups (to give 1c), gives a compound that is insoluble in water. 
Introduction of an extra carboxyl group [40] gave the more soluble tetra-ethyl 
dicarboxy analogue DCTEIO (1b) that was a more effective antioxidant than the 
CTMIO parent [41].  
Hence here we focused on converting dicarboxy tetraethyl isoindoline 
nitroxides to fluorophore-containing nitroxides to generate probes that are responsive 
to specific cellular compartments and conditions. The ethyl groups in 5b and 8b 
should substantially decrease cellular reduction. Notably, the negative reduction 
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potential of redox couples present within the mitochondria serve to rapidly generate 
the non-radical fluorescent hydroxylamines (6b and 9b). Consequently the probe is 
predominantly “switched off” and therefore has low fluorescence emissivity, except 
in mitochondria. ROS and oxidising species should be able to re-form the nitroxide 
and therefore the levels of fluorescence from within the mitochondria are expected be 
responsive to the redox potential of redox couples within this organelle.  
 
Synthesis of tetraethyl nitroxide fluorescein and rhodamine analogues 
The synthesis of the tetraethyl nitroxide fluorescein analogue (2b) was 
achieved via the condensation of two equivalents of resorcinol with the anhydride 
generated from a dicarboxyisoindoline nitroxide, in a manner analogous to our 
previous synthesis [11] of the tetramethyl analogue 2a (Scheme 1). The nitroxide 
anhydride is readily obtained by cyclisation of the dicarboxy nitroxide (1b or 1d) in 
acetic anhydride, and reaction of this with resorcinol gives a sulfonate ester 
intermediate (not isolated) that can be reacted with NaOH to produce the fluorescein 
in the dianion form [11].  
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Scheme 2. Synthesis and inter-conversion of fluorescein-based (2) and rhodamine-based (5, 8) pro-
fluorescent nitroxides and their fluorescent hydroxylamine (3 and 9) and methoxamine (7, 10) 
analogues. (a Series R2 = CH3, b Series R2 = CH2CH3)  
 
The ortho dicarboxy substitution in the ring of the starting materials (such as 
1b), allows access to fluoresceins in good yield in a simple one pot procedure. 
Fluoresceins may also be converted to rhodamine derivatives via palladium-catalysed 
Buchwald-Hartwig amination to exchange the phenolic hydroxyl groups with 
secondary amines. This was achieved by first converting the –OH groups to triflates 
(in this case 4a and 4b) followed by Pd-catalysed amination with pyrrolidine to give 
the pyrrolidinorhodamine nitroxides as the chloride salt.  
As the fluorescence response of fluorescein is pH dependent and can be 
bleached by the light sources used in microscopy, we focused on the rhodamine 
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analogues. Product 5b was of most interest because the tetraethyl analogues possess 
enhanced stability towards bio-reduction. Furthermore, rhodamines are known to 
accumulate in mitochondria, driven by the membrane potential. The nitroxide 5b can 
be further derivatised to give the methoxyamine 7b as a positive control for 
fluorescence experiments with 5, as they should display similar localisation and 
transport as the pro-fluorescent nitroxide probes, but they are permanently fluorescent 
and unaffected by the redox environment.  
 
Comparison of reduction rates of tetra-methyl vs tetra-ethyl probes by ascorbate 
To assess the comparative rates of reduction for the fluorescein and rhodamine probes 
(2a, 2b or 5b) their reaction with ascorbate was monitored over time (Figure 2). The 
reaction of ascorbate with the tetra-ethyl analogues is significantly slower (~10-fold), 
as indicated for fluoresceins 2a and 2b, in Figure 2 and reflecting the slower ascorbate 
reduction of the parent tetraethylisoindoline nitroxides (0.081 M
-1⋅s-1) versus the 
tetramethyl system (0.74 M
-1⋅s-1) [42]. The tetra-ethyl rhodamine 5b displayed no 
apparent reduction over this time period (data not shown). Thus, the reduction of 
tetraethylnitroxides by ascorbate is slow compared to the methyl analogues (2a vs 2b) 
and not detectable for the tetraethylnitroxide/rhodamine analogue 5b. 
 
 
 
 
Figure 2. Comparative reduction rates by excess ascorbate of the fluorescein (tetra-methyl) nitroxide 
probe 2a compared to the tetra-ethyl analogue 2b. Blanks with no ascorbate addition are also displayed 
(lower light grey data points), showing no increase in fluorescence over this time, with the tetra-ethyl 
analogue 5b results being indistinguishable from the blank. A 0.5 µM concentration of fluorescein or 
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rhodamine probes (2a, 2b or 5b) was prepared in 4 mL PBS and argon was bubbled through the 
solution to lower oxygen levels. Reduction was initiated by the addition of 375 µM ascorbate (> 750 
molar excess). Fluorescence intensity was monitored over time (600 min) and the relative reduction 
rates were determined based on the slope of the graph of percentage fluorescence intensity changes 
against time. 
 
Reduction of fluorescein and rhodamine probes 2b and 8b by mitochondrial 
membranes 
 To determine whether biological systems could be more potent at reducing 
these nitroxides than ascorbate, we incubated them with isolated mitochondrial 
membranes (Figure 3). When the membranes were supplied with the respiratory 
substrate succinate, the conversion of the nitroxides 2b and 8b to the more fluorescent 
hydroxylamines could be observed (Figure 3A and B). Under these conditions, 
succinate will be oxidised by succinate dehydrogenase and thereby pass electrons on 
to the coenzyme Q pool and to all respiratory chain carriers between CoQ and oxygen, 
hence nearly all possible sites of reduction of nitroxides within the mitochondrial 
respiratory chain will be supplied with electrons and could in principle act as the site 
of reduction.  
 
A        B 
 
 
 
C 
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Figure 3. A, B Fluorescence increase over time from fluorescein probe 2b (Panel A. 2.0 M, 490nm 
ex. / 520nm em.) and rhodamine probe 8b (Panel B. 0.2 M, 550nm ex. / 575nm em.) stirred with 
mitochondrial membranes (0.02 mg) and succinate (6.7 mM) in buffer (3.0 mL). Panel C shows the 
fluorescence increase over time from fluorescein probe 2b (2.0 M, 490nm ex. / 520nm em.) stirred 
with mitochondrial membranes and succinate in buffer in a capped fluorimeter cell. Red arrows 
indicate when the cap was removed and the mixture aerated by shaking for 10 s. 
 
A lag period before the fluorescence increase occurred was evident and its 
duration was proportional to the amount of dissolved oxygen present in the closed cell, 
as the lag period could be shortened by bubbling with argon. Together, these data 
suggest that the rapid respiration of the mitochondrial membranes depleted the 
oxygen and enabled reduction of the nitroxide. This was supported by the fact that the 
lag period lengthened when the cell was stirred rapidly when open to the air to 
enhance diffusion of oxygen into the suspension. The role of dissolved oxygen in 
converting the fluorescent hydroxylamine 3b to the less fluorescent nitroxide 2b, was 
further confirmed by an experiment where respiration by the membranes was allowed 
to deplete the dissolved oxygen and then the fluorimeter cell was re-aerated by 
shaking with air for 10s. Figure 3 shows the reversible fluorescence response 
Addition of O2 by shaking in air=
= Addition of malonate
 21 
generated in this experiment. To confirm that the reduction process required electrons 
supplied by succinate, we added malonate, a competitive inhibitor of succinate 
dehydrogenase, which prevented the reduction of the nitroxide.  
When whole mitochondria were used instead of mitochondrial membranes, the 
fluorescence switch-on was much greater for the rhodamine based probe, which 
correlates to the greater uptake expected for a positively charged rhodamine 8b over 
the neutral/negatively charged fluorescein 2b (Figure 4).  
 
 
Figure 4. Fluorescence increase over time (75 min.) from fluorescein probe 2b (Red line, 0.12 M, 
490nm ex. / 520nm em.) and rhodamine probe 8b (green line, 0.2 M, 550nm ex. / 575nm em.) 
exposed to whole mitochondria in the presence of succinate (6.7 mM) in buffer (3.0 mL), open to the 
air, with RT stirring in a quartz fluorimeter cell.  
 
The same reversible cycling behaviour could be demonstrated for the 
tetraethyl rhodamine nitroxides (see SI Figure SI3), although more demanding redox 
conditions are required as expected from the limited degree of reduction arising from 
treatment with excess ascorbate.  
These data are consistent with nitroxide reduction by mitochondrial reductive 
processes that are supplied with electrons by succinate and that the lipophilic cation 
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character of the rhodamine-based probes enhances the uptake of this molecule into 
mitochondria.  
 
Visualising the localisation of the rhodamine nitroxide 5b in mitochondria within 
cells 
Simple co-localisation experiments demonstrate that the tetrethylrhodamine 
nitroxide 5b predominantly localises within the mitochondria. An overlaid image for 
cells treated with 5b and MitoTracker Green (Figure 5C) supports such mitochondrial 
localisation. There is evidence for a slightly broader distribution for 5b than for 
MitoTracker Green, as images also show some rhodamine fluorescence from within 
globular structures that were not evident with MitoTracker Green treatment. 
SoftWorx image analysis was used to determine a coefficient of correlation co-
localisation plot (Figure 5D) which shows how the two emissions (from 5b and 
MitoTracker Green) correlate on a pixel-by-pixel basis (where each spot represents a 
pixel). Based on these images, a co-localisation value of 0.7269 was obtained 
indicating that most of the 5b follows the same distribution as MitoTracker Green.  
 
 
Figure 5. Co-localisation experiments with MitroTracker Green and LysoTracker Blue with the 
rhodoamine nitroxide probe (5b) in hTERT immortalised human fibroblast cells. Panel A: Probe 5b (1 
µM) with insert highlighting typical filamentary mitochondrial structures. Panel B: MitoTracker Green 
(100 nM). Panel C: Overlay 5b and MitoTracker Green. Panel D: Correlation plot for overlaid image. 
Panel E: Probe 5b (1 µM) with insert highlighting globular bodies possibly reflecting excretion into 
lysomes / endosomes. Panel F: LysoTracker Blue (50 nM). Panel C: Overlay 5b and LysoTracker Blue.  
 
A.               B.         C.     D. 
E.            F.         G. 
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An overlaid image from cells treated with 5b compared to LysoTracker Blue 
treated cells (Figure 5G) indicates some localisation of the rhodamine probe to 
lysosomes with the other globular structures, possibly endosomes. Notably, there is 
limited fluorescence arising from the cytoplasm. This fluorescence behaviour 
correlates with 5b only reaching detectable fluorescence levels on uptake into the 
mitochondria, where it is reduced to the more fluorescent hydroxylamine (6b). Some 
subsequent excretion of 6b would account for fluorescence arising from endosomes 
and lysosomes.  
Cells treated with the rhodamine probe 5b were subsequently treated with 
either rotenone or antimycin, thereby interrupting the mitochondrial electron transport 
chain, blocking the supply of electrons to potential reducing sites and also giving rise 
to higher levels of oxidants. This would be expected to tilt the redox balance towards 
a more oxidising environment and thereby decrease the overall fluorescence 
generated. Decreased fluorescence would arise from diminished mitochondrial 
reduction of 5b and because some of the hydroxylamine 6b would be re-oxidised 
back to 5b. Flow cytometry was used to monitor cells treated with 5b, which 
confirmed that lower fluorescence arises in a dose responsive manner to 
mitochondrial inhibition (Figure 6B). The redox responsive probe MitoSox was used 
as a positive control (Figure 6C) and demonstrated a dose dependent response to both 
rotenone and antimycin, reflecting enhanced oxidising conditions in the mitochondria 
arising from inhibition. The methoxyamine 7b was used as a negative control (Figure 
6D) and this non-redox active analogue showed no dose-dependent changes in 
fluorescence. Taken together, these results support the concept that the 
hydroxylamine/nitroxide ratio controls the probe brightness. Inhibitors that deliver 
conditions producing increased levels of ROS and stronger oxidation driven switch-
on of MitoSOX, tilt the balance towards the nitroxide and lead to a decrease in the 
fluorescence response detected from cells treated with the rhodamine PFN probe 5b.  
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Figure 6. Percentage reduction in fluorescence intensity of treated hTERT immortalised human 
fibroblast cells, Fs [cells incubated with rhodamine nitroxide 5b (1 µM) for 45 min, followed by 
treatment with varying concentrations of rotenone (ROT) or antimycin (AMC)] for 15 min relative to 
blank, Fc [cells incubated with 1 µM probes for 45 min, followed by treatment with DMSO for 15 min]. 
Panel A: Cells treated with 1 µM 5b measured by flow cytometry. Panel B: Percentage reduction in 
fluorescence intensity of cell populations incubated with 5b and treated with 5 doses of 2 inhibitors. 
Panel C: Cells treated with 1 µM MitoSox. Panel D: Percentage change in fluorescence intensity for 
7b treated cells with 5 doses of two inhibitors. The results in A were analysed using Kruskal Wallis test 
with post hoc testing using the Dunn’s multiple comparison test. Data in B and C were analysed using 
One-way ANOVA with post hoc testing using the Dunn’s multiple comparison test. In all cases A, B 
and C, treatments showed significant *P values (< 0.05) compared to the blank. Results for the two 
inhibitors shown in B were only significantly different at the highest dose, but were significantly 
different in all doses indicated in C. Data in D were not significantly different P values (> 0.05) 
compared to blank. 
 
The mitochondrial membrane potential provides a driving force to accumulate 
positively charged species. The rhodamine nitroxide 5b will be taken up by the 
mitochondria as the free acid form (RCOOH) that exists in equilibrium with the 
conjugate base (Scheme 3). This will lead to greater uptake into the mitochondria due 
to the combined effect of the uptake of the weak acid driven by the pH gradient and 
the membrane potential on the fixed positive charge [43]  
A. B. 
C. 
B. 
D. 
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Scheme 3. Small equilibrium concentrations of 5b present in the RCOOH form (pro-fluorescent, dark), 
would be driven into the mitochondria by the membrane potential due to the overall positive charge on 
the molecule. Outside the mitochondria the reduction of the tetraethyl nitroxide probe is slow. Inside 
the mitochondria the probe would be rapidly reduced and loss of the free radical restores the usual 
fluorescence emission from the rhodamine fluorophore.  
 
However, the pKa of the carboxylic acid and the consequent significant 
proportion of the zwitterionic form of either 5b or 6b would slow the uptake of the 
compounds across the plasma membrane. To circumvent this, 5b was esterified to 
lock the compound as the permanently positively charged 8b and also to increase the 
hydrophobicicty, both of which enhance uptake into the cell and thus provide a 
stronger fluorescence response driven by mitochondrial action.  
There was significantly increased uptake of the rhodamine nitroxide methyl 
ester 8b compared to 5b, enabling us to achieve mitochondrial labelling at much 
lower incubation concentrations (5 nM of 8b compared to using 1 M of 5b). To 
further assess the relative uptake, we next studied the redox insensitive non-radical 
methoxyamine deriviatives (7b or 10b), which have the same fluorescence as the fully 
reduced probes, and which possess similar physicochemical properties and therefore 
reflect the fluorescence performance expected when the nitroxide (5b or 8b) is fully 
reduced to the non-radical hydroxylamine (6b or 9b).  
Figure 7 shows that when cells are incubated with the rhodamine probe 5b 
using a lower concentration of probe (5 nM), there is negligible detectable 
fluorescence (Panel A). This was also the case for the methoxamine derivative (7b) at 
this concentration (Panel B). This indicates that, at this concentration, there is 
insufficient compound taken up into the mitochondria to be detectable under these 
conditions. However, this was not the case when 8b was used at the same 
concentration (5 nM), when there was readily detectable fluorescence within the 
 26 
mitochondria. Incubation with the fully fluorescent methoxyamine derivative (10b) 
(Panel D) at the same concentration shows the signal that would be expected if all of 
the nitroxide 8b was converted to non-radical hydroxylamine 9b.  
 
 
Figure 7. Fluorescence image intensity comparison for very low concentration (5 nM) rhodamine 
nitroxides and the methyl ester and methoxyamine derivatives in hTERT immortalised human 
fibroblast cells. Panel A: Rhodamine nitroxide 5b (5 nM) Panel B: Non-radical methoxyamine (fully 
fluorescent) analogue (7b) (5 nM). Panel C: Rhodamine nitroxide methyl ester (8b) (5 nM). Panel D: 
Non-radical methoxyamine (fully fluorescent) analogue of rhodamine nitroxide methyl ester (10b) (5 
nM). 
 
A correlation plot for the rhodamine nitroxide methyl ester 8b and 
MitoTracker Green (Figure 8) indicates an increased correlation (0.9217), likely due 
to the lower concentrations used, which correspond to less induction of excretion 
pathways.  
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Figure 8. Comparison of the localisation of 1 µM of tetraethylrhodamine nitroxide 5b (Panel 
A) and 5 nM of methyl ester tetraethylrhodamine nitroxide 8b (Panel C) within hTERT immortalised 
human fibroblast cells. Co-localisation images of 5b (1 µM) and 8b (5 nM), and MitoTracker Green 
(100 nM) within mitochondria (Panels B and D). Panel F shows the correlation plot and Panel E shows 
the percentage reduction in fluorescence intensity of cell populations incubated with 8b and treated 
 
 
 
5b 
8b 
Mitotracker 
    Green 
F. E. 
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with 5 concentrations of the inhibitors rotenone and antimycin. The results shown in E were analysed 
using Kruskal Wallis test with post hoc testing using the Dunn’s multiple comparison test. Treatments 
showed significant *P values (< 0.05) compared to the blank.  
 
One of the challenges of applying intensity-based sensors such as pro-
fluorescent nitroxides is that emission intensity can be affected by other factors 
including probe concentration and laser intensity. Ideally the collection of the least 
ambiguous information requires the use of ratiometric sensing methods, for which 
spectral changes rather than intensity changes are recorded [44]. Ratiometric sensing 
is traditionally achieved by using probes that change colour in response to analytes, 
and to this end Förster resonance energy transfer (FRET)-based ratiometric sensors 
for cellular redox environment have been developed [45]. However, in theory, any 
parameter that changes with location can be measured through image mapping 
methodology that allows the determination of relative ratios. PFNs, with their short 
fluorescence lifetimes compared to their fluorescent non-radical counterparts, 
therefore offer an opportunity for lifetime-based ratiometric imaging using 
fluorescence lifetime imaging microscopy (FLIM). We demonstrate here, for the first 
time, the power of this technique using 5b.  
DLD-1 colorectal adenocarcinoma cells were treated with 5b and visualised 
by confocal microscopy. Cells were then treated with the oxidant hydrogen peroxide 
or with the inhibitors rotenone and antimycin to disrupt mitochondrial redox balance. 
By confocal imaging, it was possible to observe a decrease in fluorescence intensity 
under oxidising conditions, consistent with more probe in the oxidised, pro-
fluorescent form (Figure 9A). Fluorescence lifetime imaging was achieved using two-
photon excitation at 820 nm, and all images could be fit to bi-exponential decay with 
two fluorescence lifetimes, of 1.3 ns and 2.9 ns, corresponding to the pro-fluorescent 
radical and fluorescent non-radical respectively. Average lifetimes decreased after 
treatment with oxidants (Figure 9C-F), consistent with greater proportions of the pro-
fluorescent nitroxide radical in these conditions. These average lifetime changes 
corresponded to changes in the contribution of shorter and longer lifetimes (Figure 
9B): such values are independent of the concentration of the probe, and therefore can 
be considered to be a ratiometric output.  
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Figure 9: Fluorescence lifetime imaging microscopy enables ratiometric measurement of the 
proportions of pro-fluorescent radicals and non-radical forms. DLD-1 cells treated with 5b (100 nM, 15 
min) followed by vehicle control, rotenone (10 µM, 15 min), antimycin (10 µM, 15 min) or H2O2 (50 
µM, 15 min). Panel A. Fluorescence intensities from confocal microscope images of cells, 488 nm 
excitation, 550-650 nm emission. Panel B. % shorter (1.3 ns) lifetime from fluorescence lifetime 
imaging, 820 nm two-photon excitation, 550-650 nm emission. Panels C-F. Fluorescence lifetime 
images showing average lifetimes for C: control, D: rotenone, E: antimycin and F: H2O2. n = 3, data 
reported as mean ± st. dev. 
 
 
Discussion 
Imaging studies for both fluorescein- and rhodamine-based probes over a 
range of concentrations indicate broad distribution throughout the cell, as well as with 
higher accumulations in specific cellular compartments. At lower concentration 
treatments and influenced by exposure times, the fluoresceins are detectable mainly in 
the membranes and excretory bodies [11]. The fate of the fluorescein probe 2b taken 
up by the cell is likely to involve some reduction in the cytosol, but this would be 
slow compared to the methyl analogue 2a. It is also likely to involve entry into, and 
more rapid reduction within, the mitochondria followed by excretion of the resultant 
hydroxylamine and some amount of re-oxidation by oxygen and other oxidants. The 
fluorescein 2b displays highly reversible redox sensitivity in fluorimeter-based studies 
and flow-cytometry experiments, but is less suitable for confocal microscopy, where 
photo-bleaching may become an issue.  
In contrast, the rhodamines 5b and 8b are more robust for confocal imaging 
and also demonstrate accumulation largely within the mitochondria. There is a greater 
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degree of “switch-on” of fluorescence within these organelles, as indicated by the 
fluorescence lifetime experiments (Figure 9). The esterification of 5b to give 8b 
increases mitochondrial accumulation, such that a detectable fluorescence response 
can be obtained by cell incubations at concentrations as low as 5 nM, minimising 
impact on cell and mitochondrial membrane integrity. The reversibility of probe 
fluorescence is demonstrated by the increase and decrease of fluorescence emission 
on exposure to mitochondrial membranes and isolated mitochondria followed by 
exposure to oxygen. In cell imaging studies, the methyl ester probe 8b shows a 
significant fluorescence response to antimycin and rotenone treatment, demonstrating 
that the PFN probes 8b holds potential as a tool to monitor mitochondrial redox status.  
 
Conclusion 
 We have shown that dicarboxy nitroxides can be used to generate a new class 
of redox-responsive probes. These probes provide a real-time and reversible response 
that enables the monitoring of the mitochondrial redox state within cells and holds 
promise for the assessment of mitochondrial redox status in cells under a range of 
conditions.  
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Highlights 
 
 New fluorescent probes give reversible real-time insight into cellular redox 
status 
 
 Probe structure enhances mitochondrial retention  
 
 Reversible fluorescence switch-on predominantly occurs within mitochondria 
 
 Probe reduction, balanced by re-oxidation, controls fluorophore lifetime and 
emission 
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